Recursion Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

3,994,651

Value ($000)

16,338

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	16,338	0.0%	3,994,651	12/31/2025
2025 Q3	11/10/2025	16,812	0.0%	3,445,020	9/30/2025
2025 Q2	8/12/2025	13,101	0.0%	2,589,202	6/30/2025
2025 Q1	9/15/2025	12,053	0.0%	2,278,401	3/31/2025
2024 Q4	2/6/2025	15,372	0.0%	2,274,003	12/31/2024
2024 Q3	11/12/2024	12,789	0.0%	1,940,680	9/30/2024
2024 Q2	8/12/2024	12,388	0.0%	1,651,754	6/30/2024
2024 Q1	5/9/2024	12,094	0.0%	1,213,012	3/31/2024
2023 Q4	2/6/2024	11,742	0.0%	1,190,882	12/31/2023
2023 Q3	11/8/2023	8,858	0.0%	1,157,966	9/30/2023
2023 Q2	8/10/2023	7,476	0.0%	1,000,777	6/30/2023
2023 Q1	5/12/2023	6,563	0.0%	983,939	3/31/2023
2022 Q4	2/13/2023	7,592	0.0%	984,681	12/31/2022
2022 Q3	11/14/2022	9,624	0.0%	904,504	9/30/2022
2022 Q2	8/15/2022	3,487	0.0%	428,342	6/30/2022
2022 Q1	5/13/2022	2,672	0.0%	373,164	3/31/2022
2021 Q4	2/11/2022	6,463	0.0%	377,239	12/31/2021
2021 Q3	11/16/2021	4,206	0.0%	182,772	9/30/2021
2021 Q2	8/16/2021	6,019	0.0%	164,881	6/30/2021